Plurilock - CEO, Ian Paterson.
CEO, Ian Paterson.
Source: Plurilock.
  • Plurilock Security Inc. (PLUR) has received a purchase order worth US$146,000 from a healthcare organization in California
  • The order is for a renewal of a portfolio of security solutions, including the company’s Symantec Endpoint Security Complete
  • Cyber attacks in the healthcare sector are on the rise, creating a large need for cybersecurity solutions that protect sensitive patient and business data
  • Plurilock is an identity-centric cybersecurity solutions provider for workforces
  • Plurilock Security Inc. (PLUR) is holding steady, trading at $0.445 per share

Plurilock Security Inc. (PLUR) has received a purchase order worth US$146,000 from a healthcare organization in California.

The order is for a renewal of a portfolio of security solutions, including the company’s Symantec Endpoint Security Complete.

Plurilock has an existing customer relationship with this healthcare organization, demonstrating the company’s ongoing commitment to serve the healthcare and government verticals.

Recent contracts from various clients include a total of nearly US$3.31 million in sales since May 2021. Additionally, the company’s current revenue run rate for the 2021 fiscal year has increased by over 800% year-over-year.

Cyber attacks in the healthcare sector are on the rise, creating a large need for cybersecurity solutions that protect sensitive patient and business data.

According to a report by Herjavec Group, researchers predict that the global healthcare cybersecurity market will grow by 15 per cent year-over-year during the next five years, reaching $125 billion cumulatively from 2020 through 2025.

Plurilock is an identity-centric cybersecurity solutions provider for workforces.

The company offers world-class IT and cybersecurity solutions through its solutions division, paired with proprietary AI-driven and cloud-friendly security through its technology division.

Plurilock Security Inc. (PLUR) is holding steady, trading at $0.445 per share as of 9:41 am ET.

More From The Market Online

PharmAla Biotech launches educational portal for MDMA

PharmAla Biotech (CSE:MDMA) launches its Prescribers Portal for medical practitioners to learn more about MDMA.

BlackBerry expands AI-powered cybersecurity service

BlackBerry (TSX:BB) releases the new and expanded CylanceMDR, a managed detection and response tool backed by its Cylance AI platform.

Qualcomm stock jumps on Q2 2024 earnings

Qualcomm (NDAQ:QCOM) shares rise nearly 10 per cent early Thursday on better-than-expected adjusted earnings and strong revenue guidance.

Cancer-fighting pharma stock eyes 2027 regulatory approval

Theralase Technologies (TSXV:TLT), a cancer-fighting pharma stock, expands its team with two clinical research associates.